Adult brainstem glioma differential diagnoses: an MRI-based approach in a series of 68 patients.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 18 11 2021
accepted: 06 03 2022
revised: 24 02 2022
pubmed: 21 4 2022
medline: 22 7 2022
entrez: 20 4 2022
Statut: ppublish

Résumé

Brainstem gliomas are rare in adults. The diagnosis is often difficult, as some teams still consider brainstem biopsies dangerous and often avoid this procedure. The aim of this study was to describe differential diagnoses that can mimic brainstem glioma, to help clinicians avoid diagnostic and therapeutic mistakes, and to propose a diagnostic algorithm according to radiological presentations. The French network of adult brainstem gliomas (GLITRAD) retrospectively collected all reported cases of differential diagnoses between 2006 and 2017. The inclusion criteria were as follows: age over 18 years, lesion epicenter in the brainstem, radiological pattern suggestive of a glioma and diagnostic confirmation (histopathological or not, depending on the disease). We identified a total of 68 cases. Most cases (58/68, 85%) presented as contrast-enhancing lesions. The most frequent final diagnosis in this group was metastases in 24/58 (41%), followed by central nervous system lymphoma in 8/58 (14%). Conversely, MRI findings revealed 10/68 nonenhancing lesions. The most frequent diagnosis in this group was demyelinating disease (3/10, 30%). The risk of diagnostic mistakes illustrates the need to consider the more systematic use of a brainstem biopsy when reasonably possible. However, we propose an MRI-based approach to the differential diagnosis of gliomas to limit the risk of misdiagnosis in cases where a biopsy is not a reasonable option.

Sections du résumé

BACKGROUND BACKGROUND
Brainstem gliomas are rare in adults. The diagnosis is often difficult, as some teams still consider brainstem biopsies dangerous and often avoid this procedure. The aim of this study was to describe differential diagnoses that can mimic brainstem glioma, to help clinicians avoid diagnostic and therapeutic mistakes, and to propose a diagnostic algorithm according to radiological presentations.
METHODS METHODS
The French network of adult brainstem gliomas (GLITRAD) retrospectively collected all reported cases of differential diagnoses between 2006 and 2017. The inclusion criteria were as follows: age over 18 years, lesion epicenter in the brainstem, radiological pattern suggestive of a glioma and diagnostic confirmation (histopathological or not, depending on the disease).
RESULTS RESULTS
We identified a total of 68 cases. Most cases (58/68, 85%) presented as contrast-enhancing lesions. The most frequent final diagnosis in this group was metastases in 24/58 (41%), followed by central nervous system lymphoma in 8/58 (14%). Conversely, MRI findings revealed 10/68 nonenhancing lesions. The most frequent diagnosis in this group was demyelinating disease (3/10, 30%).
CONCLUSION CONCLUSIONS
The risk of diagnostic mistakes illustrates the need to consider the more systematic use of a brainstem biopsy when reasonably possible. However, we propose an MRI-based approach to the differential diagnosis of gliomas to limit the risk of misdiagnosis in cases where a biopsy is not a reasonable option.

Identifiants

pubmed: 35441889
doi: 10.1007/s00415-022-11070-6
pii: 10.1007/s00415-022-11070-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4349-4362

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Références

Eisele S, Reardon D (2016) Adult brainstem gliomas. Cancer 122(18):2799–2809. https://doi.org/10.1002/cncr.29920
doi: 10.1002/cncr.29920 pubmed: 27327773
Hu J, Western S, Kesari S (2016) Brainstem glioma in adults. Front Oncol 6:180. https://doi.org/10.3389/fonc.2016.00180
doi: 10.3389/fonc.2016.00180 pubmed: 27556016 pmcid: 4978106
Dellaretti M, Touzet G, Reyns N et al (2012) Correlation between magnetic resonance imaging findings and histological diagnosis of intrinsic brainstem lesions in adults. Neuro Oncol. 3:381–5. https://doi.org/10.1093/neuonc/nor215
doi: 10.1093/neuonc/nor215
Rachinger W, Grau S, Holtmannspötter M, Herms J et al (2009) Serial stereotactic biopsy of brainstem lesions in adults improves diagnostic accuracy compared with MRI only. J Neurol Neurosurg Psychiatry 80:1134–1139
doi: 10.1136/jnnp.2009.174250
Nicolas Massager, Philippe David, Serge Goldman, Benoite Pirotte et al (2000) Combined magnetic resonance imaging and positron emission tomography-guided sterotactic biopsy in brainstem mass lesions: diagnostic yield in a series of 30 patients. J Nuerosurg 93:951–957
doi: 10.3171/jns.2000.93.6.0951
Chad D, Abernathey CD, Camacho A, Kelly PJ (1989) Stereotaxic suboccipital transcerebellar biopsy of pontine mass lesions. J Neurosurg. 70(2):195–200. https://doi.org/10.3171/jns.1989.70.2.0195
doi: 10.3171/jns.1989.70.2.0195
Gonçalves-Ferreira AJ, Herculano-Carvalho M, Pimentel J (2003) Stereotactic biopsies of focal brainstem lesions. Surg Neurol. 4:311–20. https://doi.org/10.1016/s0090-3019(03)00379-3
doi: 10.1016/s0090-3019(03)00379-3
Samadani U, Stein S, Moonis G, Sonnad SS, Bonura P, Judy KD (2006) Stereotactic biopsy of brain stem masses: Decision analysis and literature review. Surg Neurol. 5:484–90. https://doi.org/10.1016/j.surneu.2006.05.056
doi: 10.1016/j.surneu.2006.05.056
Kickingereder P, Willeit P, Simon T, Ruge MI (2013) Diagnostic value and safety of stereotactic biopsy of brainstem tumors: a systematic review and meta-analysis of 1480 cases. Neurosurgery 72:873–881
doi: 10.1227/NEU.0b013e31828bf445
Rajshekhar V, Chandy MJ (1995) Computerized tomography-guided stereotactic surgery for brainstem masses: a risk-benefit analysis in 71 patients. J. Neurosurg. 82:976–981
doi: 10.3171/jns.1995.82.6.0976
Boviatsis EJ, Kouyialis AT, Stranjalis G, Korfias S, Sakas D (2003) CT-guided stereotactic biopsies of brain stem lesions: personal experience and literature review. Neurol Sci 24:97–102
doi: 10.1007/s10072-003-0093-3
Friedman WA, Sceats J, Nestok B et al (1989) The incidence of unexpected pathological findings in an image-guided biopsy series: a review of 100 consecutive cases. Neurosurgery 25:180–184
doi: 10.1227/00006123-198908000-00005
Mehta VS, Chandra PS, Singh PK, Garg A, Rath GK (2009) Surgical considerations for “intrinsic” brainstem gliomas: proposal of a modification in classification. Neurology India 3:274–281
Chen SY, Chen CH, Sun MH, Lee HT, Shen CC (2011) Stereotactic biopsy for brainstem lesion: comparison of approaches and reports of 10 cases. J Chin Med Assoc 74(3):110–4. https://doi.org/10.1016/j.jcma.2011.01.024
doi: 10.1016/j.jcma.2011.01.024 pubmed: 21421204
Mathon B (2021) Stereotactic biopsies of brainstem lesions: dilemma on the best trajectory. Acta Neurochir 164(3):745–746
doi: 10.1007/s00701-021-04924-x
Jung IH (2021) Stereotactic biopsy for adult brainstem lesions: a surgical approach and its diagnostic value according to the 2016 World Health Organization Classification. Cancer Med 10:7514–7524
doi: 10.1002/cam4.4272
Jaradat A (2021) Stereotactic biopsy for adult brainstem lesions: which approach? Acta Neurochir 163:1957–1964
doi: 10.1007/s00701-021-04733-2
Pafundi D (2013) Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study. Neuro-Oncology 15(8):1058–1067. https://doi.org/10.1093/neuonc/not002
doi: 10.1093/neuonc/not002 pubmed: 23460322 pmcid: 3714146
Zukotynski K (2017) (2017) Correlation of 18 F-FDG PET and MRI apparent diffusion coefficient histogram metrics with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium. J Nucl Med 58(8):1264–1269. https://doi.org/10.2967/jnumed.116.185389
doi: 10.2967/jnumed.116.185389 pubmed: 28360212 pmcid: 5537615
Morana G (2020) Correlation of multimodal 18F-DOPA PET and conventional MRI with treatment response and survival in children with diffuse intrinsic pontine gliomas. Theranostics 10(26):11881–11891. https://doi.org/10.7150/thno.5059
doi: 10.7150/thno.5059 pubmed: 33204317 pmcid: 7667677
Tinkle C (2019) Evaluation of 11C-methionine PET and anatomic MRI associations in diffuse intrinsic pontine glioma. J Nucl Med 60(3):312–319
doi: 10.2967/jnumed.118.212514
Abdullah A (2018) Value of 18 F-FET PET in adult brainstem glioma. Clin Imaging 51:68–75
doi: 10.1016/j.clinimag.2018.01.015
Abdelaziz O, Eshra M, Belal A (2016) Diagnostic value of magnetic resonance spectroscopy compared with sterotactic biospy of intra axial brain lesions. J. Neurol Sur A Cent Eur Neurosurg 4:283–290
Psimaras D, Bonnet C, Heinzmann A, Cárdenas G, Hernández José Luis S, Tungaria A, Behari S, Lacrois D, Mokhtari K, Karantoni E, Sokrab Tag E, Idris Mohamed N, Sönmez G, Caumes E, Roze E (2014) Solitary tuberculous brain lesions: 24 new cases and a review of the literature. Rev Neurol (Paris). 170(6–7):454–63
doi: 10.1016/j.neurol.2013.12.008
Sadashiva N, Tiwari S, Shukla D, Bhat D, Saini J, Somanna S, Devi BI (2017) Isolated brainstem tuberculomas. Acta Neurochir (Wien) 159(5):889–897
doi: 10.1007/s00701-017-3108-1
Fuentes S, Delsanti C, Metellus P et al (2006) Brainstem metastases: management using gamma knife radiosurgery. Neurosurgery 58(1):37–4
doi: 10.1227/01.NEU.0000190655.95669.5C
Yoo TW, Park ES, Kwon DH, Kim CJ (2011) Gamma knife radiosurgery for brainstem metastasis. J Korean Neurosurg Soc 4:299–303
doi: 10.3340/jkns.2011.50.4.299
Yen CP, Sheehan J, Patterson G, Steiner L (2006) Gamma knife surgery for metastatic brainstem tumors. J Neurosurg 105(2):213–9
doi: 10.3171/jns.2006.105.2.213
Patel A, Mohammadi H, Dong T, Shiue KR, Frye D, Le Y, Ansari S, Watson GA, Miller JC, Lautenschlaeger T (2018) Brainstem metastases treated with Gamma Knife stereotactic radiosurgery: the Indiana University Health experience. CNS Oncol 1:15–23. https://doi.org/10.2217/cns-2017-0029
doi: 10.2217/cns-2017-0029
Duc NM (2020) The role of diffusion tensor imaging metrics in the discrimination between cerebellar medulloblastoma and brainstem glioma. Pediatr Blood Cancer 67(9):e28468. https://doi.org/10.1002/pbc.28468
doi: 10.1002/pbc.28468 pubmed: 32588986
Minh TP (2020) The role of apparent diffusion coefficient in the differentiation between cerebellar medulloblastoma and brainstem glioma. Neurol Int 12(3):34–40. https://doi.org/10.3390/neurolint12030009
doi: 10.3390/neurolint12030009
Duc NM (2020) The effects of applying apparent diffusion coefficient parameters on the differentiation between fourth ventricular ependymoma and diffuse intrinsic pontine glioma. J Child Sci 10:e169–e174
doi: 10.1055/s-0040-1718897

Auteurs

Alberto Duran-Peña (A)

Service de Neurologie 2, Division Mazarin CHU Pitié-Salpêtrière, Paris, France.

François Ducray (F)

Service de Neuro-Oncologie, Hôpital Pierre Wertheimer, CHU Lyon, Lyon, France.

Carole Ramirez (C)

Service de Neurochirurgie, Hôpital Roger Salengro, CHU Lille, Lille, France.

Luc Bauchet (L)

Service de Neurochirurgie, CHU Montpellier, Montpellier, France.

Jean Marc Constans (JM)

Service de Neuroradiologie, CHU Amiens, Amiens, France.

Sylvie Grand (S)

Service de Neuroradiologie, CHU Grenoble Alpes, Grenoble, France.

Jean Sébastien Guillamo (JS)

Service de Neurologie, CHU Nîmes Caremeau, Nîmes, France.

Delphine Larrieu-Ciron (D)

Service de Neurologie, CHU Poitiers, Poitiers, France.

Didier Frappaz (D)

Service d'Oncologie, Centre Léon Bérard, Lyon, France.

Nadya Pyatigorskaya (N)

Service de Neuroradiologie, CHU Pitié-Salpêtrière, Paris, France.

Julien Savatovsky (J)

Service de Neuroradiologie, Fondation Ophtalmologique Rothschild, Paris, France.

Hugues Loiseau (H)

Service de Neurochirurgie, CHU Bordeaux, Bordeaux, France.

Nadine Martin Duverneuil (NM)

Service de Neuroradiologie, CHU Pitié-Salpêtrière, Paris, France.

Florence Laigle-Donadey (F)

Service de Neurologie 2, Division Mazarin CHU Pitié-Salpêtrière, Paris, France. florence.laigle-donadey@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH